Evidence map›Paper›PMID 32638182›Full record

ArticleApoptosis : an international journal on programmed cell death2020

The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis.

Mehrdad Ghashghaeinia, Pavla Koralkova, Daniela Giustarini, Renata Mojzikova, Birgit Fehrenbacher, Peter Dreischer, Martin Schaller, Ulrich Mrowietz, Antonio Martínez-Ruiz, Thomas Wieder and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Apoptosis and eryptosis: similarities and differences.Apoptosis : an international journal on programmed cell death · 2024
    Review
  6. Article
  7. Article
  8. Casein kinase 1α mediates eryptosis: a review.Apoptosis : an international journal on programmed cell death · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Mehrdad GhashghaeiniaPsoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany. mghashghaeinia@dermatology.uni-kiel.de.ORCID 0000-0002-1740-594X
Pavla KoralkovaDepartment of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic.ORCID 0000-0001-7970-1501
Daniela GiustariniDepartment of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy.
Renata MojzikovaDepartment of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic.
Birgit FehrenbacherDepartment of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany.
Peter DreischerPhysiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany.
Martin SchallerDepartment of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany.
Ulrich MrowietzPsoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany.
Antonio Martínez-RuizUnidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.ORCID 0000-0001-5394-9824
Thomas WiederPhysiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany.
Vladimir DivokyDepartment of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic.ORCID 0000-0003-0202-245X
Ranieri RossiDepartment of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy.
Florian LangPhysiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany.
Martin KöberleDepartment of Dermatology and Allergology, School of Medicine, Technical University of Munich, Biedersteinerstr. 29, 80802, München, Germany.ORCID 0000-0001-6825-2667
University of Tübingen · DEPalacký University Olomouc · CZUniversity of Siena · ITCentro de Investigación en Red en Enfermedades Cardiovasculares · ESClinical Research Center Kiel · DETechnical University of Munich · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Costunolide, a natural sesquiterpene lactone, has multiple pharmacological activities such as neuroprotection or induction of apoptosis and eryptosis. However, the effects of costunolide on pro-survival factors and enzymes in human erythrocytes, e.g. glutathione and glucose-6-phosphate dehydrogenase (G6PDH) respectively, have not been studied yet. Our aim was to determine the mechanisms underlying costunolide-induced eryptosis and to reverse this process. Phosphatidylserine exposure was estimated from annexin-V-binding, cell volume from forward scatter in flow cytometry, and intracellular glutathione [GSH]

Indexed as

ApoptosisBenzophenanthridinesCalciumEnzyme InhibitorsEryptosisErythrocytesGlucosephosphate DehydrogenaseGlutathioneHumansLactonesOxidative StressProtein Kinase C-alphaReactive Oxygen SpeciesSesquiterpenesBenzophenanthridinesCalciumchelerythrinecostunolideEnzyme InhibitorsG6PD protein, humanGlucosephosphate DehydrogenaseGlutathioneLactonesPRKCA protein, humanProtein Kinase C-alphaReactive Oxygen SpeciesSesquiterpenesChelerythrineCostunolideEryptosisGlucose-6-phosphate dehydrogenase (G6PDH)GlutathionePhosphatidylserine exposure

Identifiers

PMID32638182
PMCPMC7527323
OpenAlexW3041634644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.